What is Clinical Connectomics?

This emerging field is poised to transform the way we diagnose, treat, and understand neurological conditions by mapping the intricate connections within the brain.

Harnessing advanced imaging technologies and computational methods, Clinical Connectomics unveils the complex network of neural circuits that underlie cognitive function and behavior. From neurodevelopmental disorders to neurodegenerative diseases, this groundbreaking approach offers unprecedented insights into the inner workings of the brain.

At the forefront of innovation, Clinical Connectomics is paving the way for personalized medicine, enabling tailored interventions that preserve or target specific neural pathways. By deciphering the brain's connectivity patterns, clinicians can optimize treatment strategies and improve patient outcomes like never before.

For example, in neurosurgery, Clinical Connectomics is revolutionizing precision procedures. Surgeons utilize connectomic maps to navigate intricate neural pathways during delicate operations, such as tumor resections and epilepsy surgeries. By visualizing the brain's connectivity in real-time, surgeons can minimize damage to critical areas, leading to improved surgical outcomes and reduced risk of postoperative complications.

In neurology, Clinical Connectomics is transforming diagnostics and treatment planning. Neurologists leverage connectomic data to identify abnormal connectivity patterns associated with neurological disorders like Alzheimer's Disease, Chronic Headaches, Stroke, and Parkinson's disease. This enables early detection, accurate diagnosis, and personalized treatment approaches tailored to each patient's unique brain connectivity profile.

In radiation oncology, Clinical Connectomics is optimizing cancer treatment strategies. Oncologists use connectomic analysis to map out tumor-associated neural networks that may be impacted. By incorporating connectomic data into treatment planning, radiation oncologists can deliver precise radiation doses while sparing healthy brain tissue, maximizing therapeutic dosing, and minimizing side effects.

In mental health, Clinical Connectomics is shedding light on the neural basis of psychiatric disorders. Psychiatrists leverage connectomic insights to unravel the underlying brain circuitry implicated in conditions such as depression, schizophrenia, and anxiety disorders. This deeper understanding of neural connectivity patterns opens new avenues for targeted interventions, including neuromodulation techniques and personalized psychotherapy approaches, leading to more effective treatments and improved patient outcomes.

Across all of neuroscience, Clinical Connectomics is driving innovation and transforming patient care. By harnessing the power of connectomic analysis, healthcare professionals are unlocking new possibilities for precision medicine, revolutionizing healthcare across diverse specialties and enhancing the lives of patients worldwide.

Leadership Team

  • Michael Ivan, MD

    University of Miami

  • Randy D'Amico, MD

    Lenox Hill Hospital

  • John Reitano, MD

    Delve Psychiatry

  • Jason Sheehan, MD/PhD

    University of Virginia

  • Antonio Di Ieva, MD/PhD

    Macquarie University

  • Simon Hanft, MD

    Westchester Medical Center

  • Alexander Mauskop, MD

    New York Headache Center

  • Jonathan Sherman, MD

    Rutgers Cancer Institute

  • Jacky Yeung, MD

    Yale University, Yale New Haven Hospital

  • Brad Zacharia, MD

    Penn State University

  • Lloyd Zucker, MD

    Delray Medical Center, Brain&Spine S. FLA

  • Richard Bucholz, MD

    St Louis University

  • Alexander Weil, MD

    University of Montreal

  • Gary Nugent, BSN/BA

    Co-Founder & Managing Director

Empowerment Through Connectivity

Join us in the journey of knowledge exchange and innovation. Share your insights and experiences with a community dedicated to pushing boundaries and embracing new ideas.